India to United States: Dasatinib Export Trade Route
India has recorded 27 verified shipments of Dasatinib exported to United States, representing a combined trade value of $5.2M USD. This corridor is served by 8 active Indian exporters, with an average shipment value of $192.4K USD. The leading Indian exporter is EUGIA PHARMA SPECIALITIES LIMITED, which accounts for 42% of total export value with 9 shipments worth $2.2M USD. On the buying side, DR REDDYS LABORARORIES, INC is the largest importer in United States with $1.6M USD in purchases. The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, DR.REDDY'S LABORATORIES LTD, DR REDDY S LABORATORIES LTD — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Dasatinib corridor is one of India's established pharmaceutical export routes, with 27 shipments documented worth a combined $5.2M USD. The route is dominated by EUGIA PHARMA SPECIALITIES LIMITED, which alone accounts for roughly 42% of all export value, reflecting the consolidated nature of India's dasatinib manufacturing sector.
Across 8 active suppliers, the average shipment value stands at $192.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (65%) and air (15%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 25.6%, placing it at rank #11 among India's top dasatinib export destinations globally.
On the import side, key buyers of Indian dasatinib in United States include DR REDDYS LABORARORIES, INC, AUROBINDO PHARMA USA INC, DR REDDYS LABORATORIES INC and 6 others. DR REDDYS LABORARORIES, INC is the single largest importer with 6 shipments valued at $1.6M USD.
Route Characteristics
- Average transit16 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portHyderabad Air Cargo
Market Position
- Global rank#11
- Annual growth+25.6%
- Demand growth+23.4%
- Regulatory ease65/100
Top 10 Indian Dasatinib Exporters to United States
Showing top 10 of 8 Indian suppliers exporting Dasatinib to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EUGIA PHARMA SPECIALITIES LIMITED Avg $241.9K per shipment | 9 | $2.2M | 41.9% |
| 2 | DR.REDDY'S LABORATORIES LTD Avg $267.8K per shipment | 6 | $1.6M | 30.9% |
| 3 | DR REDDY S LABORATORIES LTD Avg $235.1K per shipment | 6 | $1.4M | 27.1% |
| 4 | MYGENIC HEALTHCARE PRIVATE LIMITED Avg $753 per shipment | 1 | $753 | 0.0% |
| 5 | GLOBYZ BIOPHARMA PRIVATE LIMITED Avg $179 per shipment | 2 | $357 | 0.0% |
| 6 | ATLAS ENTERPRISES Avg $193 per shipment | 1 | $193 | 0.0% |
| 7 | KOIT BIOPHARMA PRIVATE LIMITED Avg $149 per shipment | 1 | $149 | 0.0% |
| 8 | QPS BIOSERVE INDIA PRIVATE LIMITED Avg $0 per shipment | 1 | $0 | 0.0% |
This table shows the top 10 of 8 Indian companies exporting dasatinib to United States, ranked by total trade value. The listed exporters are: EUGIA PHARMA SPECIALITIES LIMITED, DR.REDDY'S LABORATORIES LTD, DR REDDY S LABORATORIES LTD, MYGENIC HEALTHCARE PRIVATE LIMITED, GLOBYZ BIOPHARMA PRIVATE LIMITED, ATLAS ENTERPRISES, KOIT BIOPHARMA PRIVATE LIMITED, QPS BIOSERVE INDIA PRIVATE LIMITED. EUGIA PHARMA SPECIALITIES LIMITED is the dominant supplier with 9 shipments worth $2.2M USD, giving it a 42% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Top 10 Dasatinib Importers in United States
Showing top 10 of 9 known buyers in United States receiving Dasatinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian dasatinib in United States include DR REDDYS LABORARORIES, INC, AUROBINDO PHARMA USA INC, DR REDDYS LABORATORIES INC, AUROBINDO PHARMA USA., INC,, MCALLEN MAILBOX CENTER VERONICA HERN, among 9 total buyers. The largest importer is DR REDDYS LABORARORIES, INC, accounting for $1.6M USD across 6 shipments — representing 31% of all dasatinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DR REDDYS LABORARORIES, INC | 6 | $1.6M | 30.9% |
| 2 | AUROBINDO PHARMA USA INC | 5 | $1.6M | 30.0% |
| 3 | DR REDDYS LABORATORIES INC | 6 | $1.4M | 27.1% |
| 4 | AUROBINDO PHARMA USA., INC, | 4 | $617.6K | 11.9% |
| 5 | MCALLEN MAILBOX CENTER VERONICA HERN | 1 | $753 | 0.0% |
| 6 | TO THE ORDER | 2 | $357 | 0.0% |
| 7 | S LO SA DE CV | 1 | $193 | 0.0% |
| 8 | COMERCIALIZADORA MEDENOR SA DE CV | 1 | $149 | 0.0% |
| 9 | SOCIETAL GAINESVILLE LLC | 1 | $0 | 0.0% |
Top 10 Dasatinib Formulations Imported by United States
Showing top 10 of 26 product formulations shipped on the India to United States Dasatinib route, ranked by trade value
United States imports a wide range of dasatinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — DASATINIB TABLET 100MG 30'S USA(5041X30S=151230) — accounts for $1.0M USD across 1 shipments. There are 26 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DASATINIB TABLET 100MG 30'S USA(5041X30S=151230) | 1 | $1.0M | 19.9% |
| 2 | DASATINIB TABLET 100MG 30 s 4306 X 30 sPACK 129180 NOS | 1 | $860.6K | 16.6% |
| 3 | DASATINIB TABLETS 100 MG DASATINIB TABLETS 100 MG US 30 S COUNT HDPE PACK QTY 1794 PACKS | 1 | $458.0K | 8.8% |
| 4 | DASATINIB TABLETS 100 MG 30 S | 1 | $436.4K | 8.4% |
| 5 | DASATINIB TABLETS 100 MG DASATINIB TABLETS 100MG US 30 S COUNT HDPE PACK QTY 1712 PACKS | 1 | $432.7K | 8.3% |
| 6 | DASATINIB TABLETS 50 MG (DASATINIB TABLETS 50MG - US (60 S COUNT, HDPE PACK))(QTY : 777 PACKS) | 1 | $218.7K | 4.2% |
| 7 | DASATINIB TABLET 50MG 60 s 808 X 60 s PACK 48480 NOS | 1 | $179.2K | 3.4% |
| 8 | DASATINIB TABLET 50MG 60'S USA (776X60S=46560) | 1 | $176.4K | 3.4% |
| 9 | DASATINIB TABLETS 80 MG 30 s | 1 | $171.6K | 3.3% |
| 10 | DASATINIB TABLETS 100 MG (DASATINIB TABLETS 100MG - US (30 S COUNT, HDPE PACK))(QTY : 651 PACKS) | 1 | $167.2K | 3.2% |
Showing top 10 of 26 Dasatinib formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 65% sea for bulk, 15% air for urgent orders.
Top Ports of Origin
Hyderabad Air Cargo handles the highest volume with 11 shipments. Transit time averages 16 days by sea.
Market Dynamics
India's dasatinib exports to United States are driven primarily by a handful of large-scale manufacturers. EUGIA PHARMA SPECIALITIES LIMITED with 9 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, DR.REDDY'S LABORATORIES LTD, DR REDDY S LABORATORIES LTD — together account for 100% of total trade value on this route. The average shipment value of $192.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as dasatinib tablet 100mg 30 s 4306 x 30 spack 129180 nos and dasatinib tablets 100 mg dasatinib tablets 100 mg us 30 s count hdpe pack qty 1794 packs, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, DR REDDYS LABORARORIES, INC is the largest importer with 6 shipments worth $1.6M USD — representing 31% of all dasatinib imports from India on this route. A total of 9 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $5.2M
- Avg. Shipment
- $192.4K
- Suppliers
- 8
- Buyers
- 9
- Transit (Sea)
- ~16 days
- Annual Growth
- +25.6%
Reverse Direction
United States → India — Dasatinib (Import)Other Dasatinib Routes
Unlock the Full India to United States Dasatinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 27 shipments on this route.
Frequently Asked Questions — India to United States Dasatinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Dasatinib to United States?
The leading Indian exporters of Dasatinib to United States are EUGIA PHARMA SPECIALITIES LIMITED, DR.REDDY'S LABORATORIES LTD, DR REDDY S LABORATORIES LTD. EUGIA PHARMA SPECIALITIES LIMITED holds the largest market share at approximately 42% of total trade value on this route.
Q What is the total value of Dasatinib exports from India to United States?
India exports Dasatinib to United States worth approximately $5.2M USD across 27 recorded shipments. The average value per shipment is $192.4K USD.
Q Which ports does India use to ship Dasatinib to United States?
The most active port of origin is Hyderabad Air Cargo with 11 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 65% of shipments going by sea and 15% by air.
Q How long does shipping take from India to United States for Dasatinib?
The average transit time for Dasatinib shipments from India to United States is approximately 16 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United States Dasatinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 25.6% with demand growth tracking at 23.4%. The route is ranked #11 among India's top Dasatinib export destinations globally.
Q How many suppliers are active on the India to United States Dasatinib route?
There are currently 8 active Indian suppliers exporting Dasatinib to United States. The market is moderately concentrated with EUGIA PHARMA SPECIALITIES LIMITED accounting for 42% of total shipment value.
Q Who are the main importers of Dasatinib from India in United States?
The leading importers of Indian Dasatinib in United States include DR REDDYS LABORARORIES, INC, AUROBINDO PHARMA USA INC, DR REDDYS LABORATORIES INC, AUROBINDO PHARMA USA., INC,, MCALLEN MAILBOX CENTER VERONICA HERN. DR REDDYS LABORARORIES, INC is the largest buyer with 6 shipments worth $1.6M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Dasatinib.
- 2.Supplier/Buyer Matching: 8 Indian exporters and 9 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 27 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
27 Verified Shipments
8 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists